Both in Pharmaceuticals
vTv Therapeutics vs Perspective Therapeutics
Over the past year VTVT returned −3.6% and CATX returned −62.7%; their daily moves had a correlation of 0.20.
VTVT −3.6% CATX −62.7%Growth of $1, one year, split-adjusted
| Metric | VTVT | CATX |
|---|---|---|
| Price | $24.03 | $0.8702 |
| Market cap | $95.0M | $99.3M |
| Today | +2.04% | −1.11% |
| 1 month | −20.0% | −63.1% |
| 6 months | −24.1% | −77.2% |
| Year to date | −39.9% | −68.4% |
| 1 year | +2.7% | −66.5% |
| Revenue growth (YoY) | — | −72.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −33069.1% |
| P/E (TTM) | — | — |
| Price / sales | 2.6× | 242.9× |
| Net cash | $86.6M | $235.3M |
| Dividend yield | — | — |
| Volatility (60d) | 41.4% | 117.1% |
| Short % of float | 9.7% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).